Abstract:ABSTRACT Gut dysbiosis is closely related to dysregulated microRNAs (miRNAs) in the intestinal epithelial cells, which plays an important role in the pathogenesis of Crohn’s disease (CD). We investigated the relationship between fecal gut microbiome (GM) and intestinal tissue miRNAs in different stages of pediatric CD. Metagenomic analysis and miRNA sequencing were conducted to examine the GM and intestinal miRNA profiles of CD patients before and after clinical induction therapy and the controls. Twenty-seven newly diagnosed, therapy-naïve pediatric patients with active CD and 11 non-inflammatory bowel disease (IBD) controls were recruited in this study. Among CD patients, 11 patients completed induction treatment and reached clinical remission. Both GM and miRNA profiles were significantly changed between CD patients and controls. Seven key bacteria were identified at species level including Defluviitalea raffinosedens , Thermotalea metallivorans , Roseburia intestinalis , Dorea sp. AGR2135, Escherichia coli , Shigella sonnei , and Salmonella enterica , the exact proportions of which were further validated by real-time quantitative PCR analysis. Eight key miRNAs were also identified including hsa-miR-215-5p, hsa-miR-194-5p, hsa-miR-12135, hsa-miR-509-3-5p, hsa-miR-212-5p, hsa-miR-4448, hsa-miR-501-3p, and hsa-miR-503-5p. The functional enrichment analysis of differential miRNAs indicated the significantly altered cyclin protein, cyclin-dependent protein, and cell cycle pathway. The close interactions between seven key bacteria and eight key miRNAs were further investigated by miRNA target prediction. The association between specific miRNA expressions and key gut bacteria at different stages of CD supported their important roles as potential molecular biomarkers. Understanding the relationship between them will help us to explore the molecular mechanisms of CD. IMPORTANCE Since previous studies have focused on the change of the fecal gut microbiome and intestinal tissue miRNA in pediatric Crohn’s disease (CD), the relationship between them in different stages is still not clear. This is the first study to explore the gut microbiota and miRNA and their correlations with the Pediatric Crohn’s Disease Activity Index (PCDAI). Crohn’s Disease Endoscopic Index of Severity (CDEIS), and calprotectin, by applying two omics approach in three different groups (active CD, CD in remission with exclusive enteral nutrition or infliximab induction therapy, and the healthy controls). Both gut microbiome structure and the miRNA profiles were significantly changed in the different stage of CD. Seven key gut microbiome at species and eight key miRNAs were found, and their close interactions were further fully investigated by miRNA target prediction.

Association of endoscopic findings and histological alterations in pediatric Crohn's disease

The role of upper gastrointestinal endoscopy in the diagnosis of pediatric inflammatory bowel disease

Pediatric Crohn's Disease in the Upper Gastrointestinal Tract: Clinical, Laboratory, Endoscopic, and Histopathological Analysis

A Multifaced Aspect of Clostridium difficile Infection in Pediatric Patients with Inflammatory Bowel Disease: Case Series and Literature Review

[Clinical and Colonoscopic Characteristics of Pediatric Inflammatory Bowel Disease].

Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn’s Disease: Before and after Induction Therapy

Mucosal Architectural Change is an Important Feature in Distinguishing Crohn's Disease from Others in Terminal Ileum Ulcer Biopsy

P109 Analysis of the Clinical, Gastroscopic, and Pathological Features of Upper Gastrointestinal Lesions in Crohn’s Disease

Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature

Endoscopic and clinical features of Crohn disease

P327 Characteristics of esophago-gastro-duodenal Crohn's disease in the biologic era: a nationwide study of the Young GETECCU Group

P292 Endoscopic findings in ileocolic anastomoses: Crohn's disease vs oncologic surgery

Changes in the gut mycobiome in pediatric patients in relation to the clinical activity of Crohn's disease

Colonoscopy and biopsy in the diagnosis of pediatric Crohn's disease

Prevalence and clinical significance of esophageal abnormalities in children with celiac disease

Analysis of Clinical, Endoscopic, and Pathological Features of Upper Gastrointestinal Tract Lesions in Crohn's Disease

Oral and Otorhinolaryngological Findings in Adults Who Were Diagnosed With Pediatric Onset Crohn's Disease: A Controlled Study

De Novo Crohn's Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch-Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN

Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease

Correlation Between Endoscopic and Histological Validated Scoring Indices in Crohn's Disease.

Structural brain morphometry differences and similarities between young patients with Crohn's disease in remission and healthy young and old controls